Trials / Completed
CompletedNCT04901065
Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs
Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs: a Randomized, Double-Blinded, Placebo Controlled-Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Evelyne D.Trottier · Academic / Other
- Sex
- All
- Age
- 8 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Since the beginning of the COVID-19 pandemic, nasopharyngeal swabs (NPS) have been recommended to detect the virus. This procedure has been reported to be painful by 85% of children The aim of the study was to assess whether pretreatment with topical lidocaine reduces the discomfort experienced by children during a nasopharyngeal swab. This was a RCT among children aged 8-17 years old who need a NPS. The primary outcome was pain intensity as measured by the Visual Analog Scale .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xylocaine | The study intervention was the administration of 10 mg of intranasal lidocaine in one nostril using 1 spray of 0.1mL of a 10% lidocaine solution 5 minutes before NPS. This was done using the standard long nozzle |
| DRUG | Placebo | The control group received the placebo with the same application technique using an empty bottle of lidocaine 10% with the same long nozzle for delivery |
Timeline
- Start date
- 2021-05-11
- Primary completion
- 2021-06-07
- Completion
- 2021-06-07
- First posted
- 2021-05-25
- Last updated
- 2021-09-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04901065. Inclusion in this directory is not an endorsement.